asset sale
Myriad Genetics to Sell Vectra DA Business, Reorganize International Presence
The changes follow a strategic review and are part of the company's previously announced plans for growing its revenues and reducing costs.
NantHealth Q1 Revenues Decline 10 Percent
The company turned its first-ever quarterly profit after a series of asset sales and cutbacks in money-losing molecular tests.
NantHealth Q4 Revenues Grow 6 Percent
The company trimmed its net loss fell by three-fourths to $11.8 million in the quarter as it continues to rein in costs.
Novacyt Completes Sale of Novaprep Assets
The French company sold the Novaprep assets to Belarus-based Algimed following a strategic review a year ago. It will now focus on the Primerdesign and Lab21 businesses.
Enzo Biochem Fiscal Q1 Revenues Down 5 Percent
The firm also said it is contemplating selling its therapeutics division, and appointed David Bench as its new CFO.
Oct 27, 2019
Edan Dx Acquires LGC Molecular Diagnostic Platform
Jun 27, 2019
Datavant Partners With Prognos
Jul 24, 2017